This patent has three main areas covered in its claims:
1. Induction of new kidney tissue growth.
2. Induction of kidney morphogenesis.
3. Repair of kidney tissue.
These are performed by administration of appropriate concentrations of the following proteins: OP-1, OP-2, BMP-2, BMP-4, BMP-5, BMP-6, Vg1, Vgr-1, DPP, 60A, or GDF-1.
This patent may be very important since numerous papers are currently being published using agents such as those described above for induction of tissue regeneration. For example, OP-1 is already in clinical use for non-healing spinal fusions.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.